Activity value 71india Buyer&Supplier,Last transaction date:
2026-04-22
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for kiior pharma private limited from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 5 transactions, with a transaction quantity of 210.7 and a transaction weight of 0.
Product description
THE CONSIGNMENT SHIPPED FROM INDiA CONSISTING OF 01 CARTON HAVING GROSS WEIGHT IS 1.130 KGS AND FOUND PHARMACEUTICAL RAW MATERILA AS PER LABEL PASTED ON CARTON DETAILS IS AS UNDER:. 01.TACROLIMUS USP BATCH NO TAC/N/25/011 MFG DATE 01/12/2025 EXP DATE 3
Expand
Hs code
29420090
Product tags
pharmaceutical raw material,tacrolimus usp
Product description
TACROLIMUS USP PHARMACEUTICAL RAW MATERIALS
Expand
Trade date
2025/12/31
B/L No.
——
Suppliers
kiior pharma private limited
Buyers
ms wns feild pharmaceuticals
POLs
——
PODs
ipaf
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
3219.05
Hs code
29413000
Product tags
bat,drap,tigecycline,ice,ail,atta,origin india,pharmaceutical raw material
Product description
FOUND PHARMACEUTICAL RAW MATERIAL DETAIL IS AS UNDER……… 01- TIGECYCLINE STERILE HIS, BATCH NO-JA/TCS-25008, MFG DATE-01/10/2025, EXP DATE-30/09/2028 ORIGIN INDIA QTY=01 KG... INVOICE DULY ATTESTED BY AD DRAP COC NO -IP-13C409, DATE-29/12/2025 SCANNED ATTA
Expand
Hs code
29181900
Product tags
calcium d saccharate,bat,pharmaceutical raw material
Product description
PHARMACEUTICAL RAW MATERIAL CALCIUM D SACCHARATE USP BATCH NO CS2553 MFG DATE 09-2025 EXP DATE 08-2030
Expand
Trade date
2025/12/15
B/L No.
4420422
Suppliers
kiior pharma private limited
Buyers
meezan bank
POLs
mumbai (ex bombay)
PODs
islamabad
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
282240
Hs code
29420090
Product tags
tigecycline
Product description
TIGECYCLINE STERILE HIS
Expand
Trade date
2025/12/05
B/L No.
8451136
Suppliers
kiior pharma private limited
Buyers
al baraka bank pakista
POLs
mumbai (ex bombay)
PODs
karachi
Supply area
India
Purchas area
Pakistan
Weight
——
Amount
145152
Hs code
29181990
Product tags
sac,pharmaceutical raw material,rat,calcium d
Product description
CALCIUM D SACHRATE USP PHARMACEUTICAL RAW MATERIALS
Expand
+View All
Products
Total 9
ProductsTransactionsPerDetail
bat 2100%>
pharmaceutical raw material 2100%>
ail 150%>
atta 150%>
calcium d saccharate 150%>
+View All
Hscode rank
Total 7
HSCode NameTransactionsPerDetail
HS 29181900150%>
HS 29413000150%>
Trading Area
Total 1
AreaTransactionsPerDetail
pakistan947.37%>
Port statistics
Total 1
Port NameTransactionsPerDetail
mumbai (ex bombay)421.05%>
kiior pharma private limited is india Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical raw material,ail.
According to the 52wmb.com global trade database, as of 2026-04-22, the company has completed 19 international trades,
with its main trading regions covering pakistan etc.
The core products include HS29181900,HS29413000 etc,
often transported via mumbai (ex bombay) etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on kiior pharma private limited is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.